Skip to main content
Learn
Featured
Catalyst Overview
→
Latest
Peptide News
→
Understand
How peptides work
→
Quality
Commitment
EN
/
ES
Order
Buy Catalyst
Track order
Sign in
Create account
Learn
Featured
Catalyst Overview
→
Latest
Peptide News
→
Understand
How peptides work
→
Quality
Commitment
EN
/
ES
Order
Buy Catalyst
Track order
Sign in
Create account
EN
/
ES
Science
/
Explained
Peptide News
/
Archive
Peptide News / Archive
More news articles
Browse Peptide News articles by source, category, and topic.
KNOWLEDGE IS THE FIRST STEP
Search articles
Category
All categories
Cultural Shifts
Clinical Findings
Frontier Science
Policy & Law
Access & Industry
Sort articles
Newest first
Oldest first
Title A-Z
Source A-Z
Showing 31–40 of 109 articles.
Combining two diabetes drug classes is not automatically a bigger clinical benefit
Medscape
Jul 24, 2026
At the highest dose, retatrutide cut 21% of body weight in people with type 2 diabetes
BioPharma Dive
Jul 23, 2026
Tirzepatide kept nearly 99% of prediabetes patients diabetes-free over three years
Fierce Pharma
Jul 22, 2026
GLP-1
-friendly is a label, not a standard
ABC
Jul 21, 2026
MOTS-C is a small peptide associated with mitochondria that has attracted attention in early research on metabolism
Men's Health
Jul 21, 2026
A Swedish registry signal opens an addiction-research question, not a new treatment claim
The Clinical Trial Vanguard
Jul 21, 2026
Among 167,026 people with type 2 diabetes, the
GLP-1
alcohol signal lasted six months and then went quiet
Medical Xpress
Jul 21, 2026
Fast food is testing a smaller-appetite customer
NBC News
Jul 19, 2026
GLP-1
use for weight loss nearly quadrupled in two years
New York Post
Jul 18, 2026
Weight loss drugs are being tested on overweight cats, starting with about 70
CNBC Health and Science
Jul 18, 2026
Previous
1
2
3
4
5
6
7
8
9
10
11
Next
